ClinVar Miner

Submissions for variant NM_004999.4(MYO6):c.2545C>T (p.Arg849Ter)

gnomAD frequency: 0.00001  dbSNP: rs121912561
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000605133 SCV000713729 pathogenic Rare genetic deafness 2017-10-26 criteria provided, single submitter clinical testing The p.Arg849X variant in MYO6 has been reported in 1 individual with nonsyndromi c hearing loss and segregated with disease in at least 14 affected relatives in an autosomal dominant manner (Sanggaard 2008). This variant has been identified in 1/17246 of East Asian chromosomes and 1/111636 European chromosomes by the Ge nome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs121 912561). This nonsense variant leads to a premature termination codon at positio n 849, which is predicted to lead to a truncated or absent protein. Truncating o r loss-of-function variants in the MYO6 gene have been associated with autosomal recessive congenital sensorineural hearing loss (Ahmed 2003) as well as autosom al dominant postlingual/late-onset progressive sensorineural hearing loss with v ariable onset and severity (Hilgert 2008, Sanggaard 2008, Neveling 2013, Schrauw en 2013, Volk 2013). In summary, this variant meets criteria to be classified as pathogenic for nonsyndromic hearing loss in an autosomal dominant manner based upon the segregation studies in the reported family and its predicted impact to the protein. ACMG/AMP Criteria applied: PVS1, PP1_S, PS4(Richards 2015).
Invitae RCV003555982 SCV004294627 pathogenic not provided 2023-07-07 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 8582). This sequence change creates a premature translational stop signal (p.Arg849*) in the MYO6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO6 are known to be pathogenic (PMID: 12687499, 18348273, 23767834, 25999546, 30582396). This variant is present in population databases (rs121912561, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with clinical features of MYO6-related conditions (PMID: 18348273, 33297549).
OMIM RCV000009113 SCV000029330 pathogenic Autosomal dominant nonsyndromic hearing loss 22 2008-04-15 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.